Association between the COMT Val158Met polymorphism and fibromyalgia susceptibility and fibromyalgia impact questionnaire score: a meta-analysis

被引：0
作者：
Young Ho Lee
Jae-Hoon Kim
Gwan Gyu Song
机构：
[1] Korea University College of Medicine,Division of Rheumatology, Department of Internal Medicine, Korea University Anam Hospital
来源：
Rheumatology International | 2015年 / 35卷
关键词：
Fibromyalgia; COMT; Polymorphism; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The aim of this study was to explore whether the catechol-O-methyltransferase (COMT) Val158Met polymorphism is associated with susceptibility to fibromyalgia and fibromyalgia impact questionnaire (FIQ) score in fibromyalgia patients. We conducted a meta-analysis of the associations of the COMT Val158Met polymorphism with fibromyalgia risk as well as FIQ score in fibromyalgia patients. A total of 993 fibromyalgia patients and 778 controls from 10 studies on the COMT Val158Met polymorphism and 538 fibromyalgia patients from 5 studies on the COMT Val158Met polymorphism and FIQ score were included in this meta-analysis. The meta-analysis revealed an association between fibromyalgia and the COMT Met/Met + Val/Met genotype in all study subjects (odds ratio (OR) 1.635, 95 % confidence interval (CI) 1.029–2.597, p = 0.037). However, stratification by ethnicity indicated no association between the Met/Met + Val/Met genotype and fibromyalgia in the European and Turkish populations (OR 1.202, 95 % CI 0.876–1.649, p = 0.255; OR 2.132, 95 % CI 0.764–5.949, p = 0.148, respectively). Analysis using other genetic models showed no association between the COMT Val158Met polymorphism and fibromyalgia. The meta-analysis also revealed that the FIQ score was significantly higher in individuals with the COMT Met/Met genotype than in those with the Val/Val genotype [weighted mean difference (WMD) = 14.39, 95 % CI 3.316–25.48, p = 0.011] and the Val/Met genotype (WMD = 5.108, 95 % CI 2.212–4.891, p = 0.021). This meta-analysis identified an association between fibromyalgia risk and the COMT Val158Met polymorphism as well as the FIQ score in fibromyalgia patients.
引用
收藏
页码：159 / 166
页数：7
相关论文
共 138 条
[1]  
Neumann L(2003)Epidemiology of fibromyalgia Curr Pain Headache Rep 7 362-368
[2]  
Buskila D(2001)Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study Rheumatology 40 743-749
[3]  
Wallace DJ(2006)Biology and therapy of fibromyalgia. Genetic aspects of fibromyalgia syndrome Arthritis Res Ther 8 218-1755
[4]  
Linker-Israeli M(2010)Quantitative role of COMT in dopamine clearance in the prefrontal cortex of freely moving mice J Neurochem 114 1745-250
[5]  
Hallegua D(1996)Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders Pharmacogenetics 6 243-27
[6]  
Silverman S(2013)Pain sensitivity in fibromyalgia is associated with catechol-O-methyltransferase (COMT) gene Eur J Pain 17 16-249
[7]  
Silver D(2012)Psychological distress in fibromyalgia patients: a role for catechol-O-methyl-transferase Val158met polymorphism Health Psychol 31 242-149
[8]  
Weisman MH(2010)Serotonin receptor (5-HT 2A) and catechol-O-methyltransferase (COMT) gene polymorphisms: triggers of fibromyalgia? Rev Bras Reumatol 50 141-S56
[9]  
Buskila D(2009)The relationship between a common catechol-O-methyltransferase (COMT) polymorphism val(158) met and fibromyalgia Clin Exp Rheumatol 27 S51-975
[10]  
Sarzi-Puttini P(2009)DRD3 Ser9Gly polymorphism is related to thermal pain perception and modulation in chronic widespread pain patients and healthy controls J Pain 10 969-691
12345678910